Levetiracetam as a first‐line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure
Journal article published in 2023 by
Sam Fairclough 
,
John Goodden ,
Paul Chumas ,
Ryan Mathew ,
Melissa Maguire
,
John Goodden ,
Paul Chumas ,
Ryan Mathew ,
Melissa Maguire
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 